EverHint Signal — SMA20 × SMA50 Crossover — November 25, 2025

What This Signal Is (Quick)

The SMA20 × SMA50 Crossover tracks fresh interactions between the 20-day and 50-day simple moving averages:

• SMA20_x_SMA50_Buy (“Golden Cross”)
  SMA(20) crosses above SMA(50): short-term momentum overtakes the medium trend.
  Often used as a bullish confirmation with 4–12 week holding windows.
• SMA20_x_SMA50_Sell (“Death Cross”)
  SMA(20) crosses below SMA(50): short-term momentum rolls under the 50-day trend.
  Often treated as a risk-reduction / exit signal or a warning of trend exhaustion.

Key characteristics:

• Two simple moving averages → stability and fewer whipsaws than fast EMAs.
• Best suited to medium-term trends with confirmed momentum.
• Typically lower trade frequency, but higher “structural quality” signals.

This is an experimental scanner and should be used for research, back-testing, and idea generation—not as a standalone trading system.

How We Ranked Today (Reader Version)

For the 2025-11-25 run:

• Total signals: 37
• Buys (Golden Cross): 17
• Sells (Death Cross): 20

For this report:

• Top 10 Buys = lowest RSI(14) among all Buy signals.
• Top 10 Sells = lowest RSI(14) among all Sell signals.

Overlays applied:

• Insider activity (last 90 days) → net open-market buying vs. selling.
• Days → Earnings (nearest upcoming earnings within 90 days, with bmo/amc timing).
• Liquidity via 20-day average dollar volume.
• Sector tags to spot rotation.

📈 Buy-Side Signals – Top 10 by RSI(14)

These are today’s Golden Cross names with the lowest RSI(14) – still bullish, but not yet at blow-off extremes.

Buy-side RSI profile

• RSI band: roughly 60–74.
• This is classic momentum continuation territory, not bargain-basement reversal.
• PFE, SPG, YUM (RSI around 60–61) are the earliest in the new trend among the Buys.
• CWST, QTWO in the low- to mid-70s are strong movers where the Golden Cross is catching a well-established advance.

Notable nuances

• SHC (RSI 68.3, insider net ≈ -$302M)
  Heavy reported insider selling alongside a Golden Cross—technicals say trend up, insider flows say “management taking chips off the table.” That tension makes SHC more suitable for short-term swings than long holds.
• KVUE, TSN, VFC
  Consumer defensive/cyclical blend with mid-60s to low-70s RSI—names benefiting from a more constructive risk tone but still anchored in staple-like demand.

Overall, Buy signals today are trend followers, not deep value: SMA20 has decisively moved above SMA50, and RSI confirms persistent strength.

📉 Sell-Side Signals – Top 10 by RSI(14)

These are Death Cross names with the lowest RSI(14) – the most technically stressed under fresh Sell signals.

Sell-side RSI profile

• RSI band: 15–35 → firmly oversold.
• QS (15.1 RSI, -$21M insider net) stands out as an extreme: Death Cross, deep oversold, and sizeable net insider selling.
• EQIX shows similar technical stress in a large, high-quality REIT—suggesting either a late-stage mean-reversion in a crowded name or early stages of bigger de-rating.

Tech & crypto-linked stack

• CORZ, APLD, NET, PLTR cluster in Technology and are either directly or indirectly tied to data centers, security, or compute-intensive themes.
• Death Cross + sub-35 RSI in this group often reflects position de-risking in higher-beta growth trades rather than business-model implosion.

Fin/Industrial component

• IBKR (RSI 30.3, insider ≈ -$3.1M) and BWXT show that even solid franchises are seeing trend fatigue. These are more like controlled descents than capitulation—the kind of names trend followers trim while fundamental investors often hold.

Field Notes – How to Read RSI and Crossovers Here

• Buy list (RSI ~60–74)
  • RSI above 50 plus a Golden Cross means trend alignment: price strength, short-term momentum, and medium-term averages all point the same way.
  • Earlier-RSI names (PFE, SPG, YUM) often provide cleaner entries than those already in the mid-70s.
• Sell list (RSI ~15–35)
  • Death Cross with RSI < 30 is a high-stress regime. These can occasionally stage sharp bounces but remain structurally damaged until SMA20 flattens and starts reclaiming SMA50.
  • The worst combos are low RSI + heavy insider selling (QS, APLD, PLTR, NET), where both flows and trend warn in the same direction.

As always, the value is in combining these technical overlays with your own fundamental and risk framework.

Vlad’s Take (EverHint)

Using today’s broad markets snapshot:

• S&P 500 (^GSPC): +1.03%
• Dow Jones (^DJI): +1.36%
• Nasdaq Composite (^IXIC): +0.98%
• Russell 2000 (^RUT): +2.00%

That’s a clear risk-on session, with small caps outperforming, which usually signals broad participation rather than a narrow mega-cap rally.

Volatility and macro:

• VIX (^VIX): 18.56, down about 9.7% on the day → volatility is elevated but falling, shifting from “alert” toward “comfortable,” not yet in ultra-low complacency.
• 10-year yield (^TNX): around 4.00%, slightly lower, supporting growth valuations at the margin.
• Bitcoin (BTC-USD): -1.33%, Ethereum (ETH-USD): -0.57% → mild risk-off in crypto even while equities rally, suggesting some rotation back into traditional assets.

Overlaying the environment on today’s SMA20 × SMA50 signals:

• The Buy table is full of quality, liquid names in Healthcare, Real Estate, Consumer, and Technology, all with RSI comfortably above 50. In a risk-on tape with easing VIX, these look like trend-following swing candidates, provided entries are staggered and risk is managed.
• The Sell table collects the stress points of this market—growthy, high-beta or richly valued names where traders have been de-risking despite today’s index strength. They’re prime candidates for risk trimming if already held, or for careful future mean-reversion watchlists once the dust settles.

Given VIX just under 20, I’d treat:

• Buys as candidates for scaled-in positions, with partial profit taking if RSI pushes into the high-70s/80s.
• Sells as places to avoid fresh longs for now unless you have a strong non-technical thesis and are ready to tolerate volatility.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/